FINWIRES · TerminalLIVE
FINWIRES

US E&Ps Gain as Oil Tops $100 on Iran Conflict, Limited Permian Growth, RBC Says

By

-- US exploration and production equities rose last week as crude prices climbed above $100 per barrel and the Middle East conflict tightened global supply expectations, RBC Capital Markets strategists said in a note on Friday.

RBC analysts said that oil-weighted E&Ps gained 5% over the period, while gas-weighted peers rose 2%, with large-cap names up 5% and small- to mid-cap names advancing 3%.

The XOP energy ETF increased 5%, tracking a 10% jump in WTI and a 6% rise in Henry Hub natural gas prices.

RBC said Q1 earnings for US E&Ps are "slightly better than expected" so far, though it noted limited signs of a broad pickup in activity.

The bank pointed to a modest uptick in Permian rig counts, which it attributed in part to constrained gas takeaway capacity rather than a broader acceleration in drilling.

Meanwhile, global crude markets were supported by ongoing geopolitical risks, including stalled diplomatic efforts and ongoing concerns about disruption in the Strait of Hormuz.

RBC said reports of potential escalation in the region added to risk premiums and pushed Brent-linked sentiment higher.

The bank also highlighted structural shifts in global supply dynamics following the UAE's effective exit from OPEC capacity discipline, which is expected to remove a significant portion of spare capacity from the group's policy toolkit.

RBC said the UAE's departure from OPEC leaves Saudi Arabia with a heavier burden in managing market stability.

Related Articles

Research

Research Alert: CFRA Lowers View On Bio-rad Laboratories To Sell From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target by $45 to $235, reflecting a 25.6x multiple of our 2026 EPS estimate (down to $9.17 from $10.15; we cut our 2027 EPS estimate to $9.97 from $10.68), a discount to BIO's three-year historical forward average of 29.5x. Rather than a dramatic cut to National Institutes of Health (NIH) funding, Congress approved a modest increase for 2026 funding, helping reduce research budget concerns that loomed during 2025. However, BIO and peers anticipate that research spending growth from academic and early-stage biotech could remain muted over the near term as academic institutions adjust. The outlook for 2026 anticipates ongoing pressure, with BIO cutting sales and margin expectations during the Q1 earnings report, citing headwinds arising from the U.S.-Iran conflict in the Middle East such as weaker diagnostics sales and higher freight and fuel costs.

$BIO
Insider Trading

Comfort Systems USA Insider Sold Shares Worth $889,890, According to a Recent SEC Filing

Pablo G. Mercado, Director, on April 30, 2026, sold 500 shares in Comfort Systems USA (FIX) for $889,890. Following the Form 4 filing with the SEC, Mercado has control over a total of 3,000 common shares of the company, with 3,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1035983/000153524626000004/xslF345X05/form4-05012026_040501.xml

$FIX
Insider Trading

Kaiser Aluminum Insider Sold Shares Worth $524,757, According to a Recent SEC Filing

Keith Harvey, Director, President & CEO, on April 29, 2026, sold 3,031 shares in Kaiser Aluminum (KALU) for $524,757. Following the Form 4 filing with the SEC, Harvey has control over a total of 94,308 common shares of the company, with 94,308 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/811596/000119312526201545/xslF345X05/ownership.xml

$KALU